Skip to main content

LEVIN CAPITAL STRATEGIES, L.P.

Position in OCUL — Ocular Therapeutix, Inc

CIK 1354821 NEW YORK, NY

Position in OCUL

as of Jun 30, 2026 · filed Jul 31, 2026
Position Value
$98,200
-$77,150 QoQ
Shares Held
10,000
-33.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#201
of 257 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in OCUL Over Time

Shares Held

Position Value (USD)

Derivatives in OCUL

reported options exposure · as of Sep 30, 2022
CallValue
$448,200
CallShares
108,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LEVIN CAPITAL STRATEGIES, L.P. holds $15,129,090 across 8 Biotechnology names. OCUL ranks #7 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 OCUL
Ocular Therapeutix, Inc
This page
10,000 $98,200

All Filings in OCUL

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $98,200 10,000
2025-09-30 $175,350 15,000
2023-09-30 $70,650 22,500
2023-06-30 $167,700 32,500
2023-03-31 $1,094,178 207,624
2022-12-31 $760,644 270,692
2022-09-30 $448,200 108,000
2022-09-30 $1,061,752 255,844
2022-06-30 $533,269 132,654
2020-06-30 $613,737 73,678
2020-03-31 $148,500 30,000